Group One Trading, L.P. Imv Inc. Transaction History

Group One Trading, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$1.07 - $1.5 $5,243 - $7,350	4,900 Added 69.01%	12,000 $17,000
Q4 2021 Feb 11, 2022	SELL	$1.22 - $1.78 $622 - $907	-510 Reduced 6.7%	7,100 $9,000
Q3 2021 Nov 12, 2021	BUY	$1.35 - $2.16 $1,633 - $2,613	1,210 Added 18.91%	7,610 $13,000
Q2 2021 Aug 10, 2021	SELL	$2.12 - $3.24 $424 - $648	-200 Reduced 3.03%	6,400 $14,000
Q1 2021 May 12, 2021	BUY	$2.92 - $4.41 $19,272 - $29,106	6,600 New	6,600 $22,000

Ticker IMV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,452,200
Description
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is P...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.